Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1253598
Max Phase: Preclinical
Molecular Formula: C77H112N16O19S2
Molecular Weight: 1629.97
Molecule Type: Small molecule
Associated Items:
ID: ALA1253598
Max Phase: Preclinical
Molecular Formula: C77H112N16O19S2
Molecular Weight: 1629.97
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC[C@H](C)[C@H](NC(=O)[C@H](CCCCNc1cc([N+](=O)[O-])cc([N+](=O)[O-])c1)NC(=O)[C@H](CSC/C=C(\C)COCc1cccc(C(=O)c2ccccc2)c1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)c1ccccc1N)[C@@H](C)O)C(=O)N[C@@H](CCSC)C(=O)O
Standard InChI: InChI=1S/C77H112N16O19S2/c1-6-48(3)65(75(104)87-62(77(106)107)32-37-113-5)90-71(100)61(30-15-19-36-82-53-40-54(92(108)109)42-55(41-53)93(110)111)85-74(103)64(46-114-38-31-47(2)44-112-45-50-21-20-24-52(39-50)67(96)51-22-8-7-9-23-51)89-70(99)59(28-13-17-34-79)86-76(105)66(49(4)95)91-72(101)60(29-14-18-35-80)84-73(102)63(43-94)88-69(98)58(27-12-16-33-78)83-68(97)56-25-10-11-26-57(56)81/h7-11,20-26,31,39-42,48-49,58-66,82,94-95H,6,12-19,27-30,32-38,43-46,78-81H2,1-5H3,(H,83,97)(H,84,102)(H,85,103)(H,86,105)(H,87,104)(H,88,98)(H,89,99)(H,90,100)(H,91,101)(H,106,107)/b47-31+/t48-,49+,58-,59-,60-,61-,62-,63-,64-,65-,66-/m0/s1
Standard InChI Key: BQGAEIPOWZAZEI-UVKZJCNESA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1629.97 | Molecular Weight (Monoisotopic): 1628.7731 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Kyro K, Manandhar SP, Mullen D, Schmidt WK, Distefano MD.. (2010) Photoaffinity labeling of Ras converting enzyme 1 (Rce1p) using a benzophenone-containing peptide substrate., 18 (15): [PMID:20619662] [10.1016/j.bmc.2010.06.024] |
Source(1):